Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’

Shares of Hims & Hers Health Inc. surged after hours on Monday as the wellness platform raised its full-year sales forecast, driven by increased personalized care offerings and a growing subscriber base for weight-loss drugs. The company’s strategic efforts to expand its services have resulted in a positive response from consumers, leading to a boost in revenue projections for the year ahead. Investors reacted positively to the news, propelling the stock price higher in after-hours trading.

Full Article